Metraipolis › archive › dc_976534baedba

Early access disparities in innovative therapies across the US, EU, China, and Japan — Europe PMC PMID:41210884

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41210884
DOI
10.3389/fmed.2025.1642882
License (as archived)
solo-consultazione
Archived
2026-11-09T02:47:27.652Z
SHA-256 of the archived text
2b157e6b49cdec428684ed16301cd5a3d8e4b8d526a02de9a8f75063cc7ce82e
Stable URL of this page
https://metraipolis.com/documento/dc_976534baedba

How to cite

Early access disparities in innovative therapies across the US, EU, China, and Japan — Europe PMC PMID:41210884 — Europe PMC (en), https://europepmc.org/article/MED/41210884 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_976534baedba (Metraipolis archive dc_976534baedba, sha256 2b157e6b49cdec428684ed16301cd5a3d8e4b8d526a02de9a8f75063cc7ce82e)
BibTeX
@misc{dc976534baedba,
  title = {Early access disparities in innovative therapies across the US, EU, China, and Japan — Europe PMC PMID:41210884},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41210884},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_976534baedba; sha256 2b157e6b49cdec428684ed16301cd5a3d8e4b8d526a02de9a8f75063cc7ce82e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41210884. Agents can read the archived copy with the MCP tool read_document.